Aller au contenu principal
Profil bibliographique

Sybrand Y. de Boer

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

33Publications signalées
1301Citations signalées
0Affiliations récentes

Les domaines associés

Inflammatory Bowel DiseaseDiabetes Treatment and ManagementColorectal Cancer Screening and DetectionNeuropeptides and Animal PhysiologyPancreatic function and diabetes

Les publications récentes

Accès ouvert 2024 article OpenAlex

Long-Term Outcomes of Early Surgery vs Endoscopy First in Chronic Pancreatitis

Charlotte L. van Veldhuisen, Marinus Abraham Kempeneers, Florence E.M. de Rijk, Stefan A.W. Bouwense et autres

Importance: Patients with painful chronic pancreatitis and a dilated pancreatic duct can be treated by early surgery or an endoscopy-first approach. Objective: To compare long-term clinical outcomes of early surgery vs an endoscopy-first approach using follow-up data from the ESCAPE randomized clinical …

nl, us (code pays fourni par la source)

34 citations JAMA Surgery
Accès ouvert 2023 article OpenAlex

Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program

Pieter H.A. Wisse, Sybrand Y. de Boer, Marco Oudkerk Pool, Jochim S. Terhaar sive Droste et autres

Abstract Background Post-colonoscopy colorectal cancers (PCCRCs) decrease the effect of colorectal cancer (CRC) screening programs. To enable PCCRC incidence reduction in the long-term, we classified PCCRCs diagnosed after colonoscopies performed in a fecal immunochemical test (FIT)-based screening program. Methods PCCRCs diagnosed after …

nl (code pays fourni par la source)

23 citations Endoscopy
Accès ouvert 2023 article OpenAlex

The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients

Femke Crouwel, Ahmed B. Bayoumy, Chris J. Mulder, Job Peters et autres

BACKGROUND: Currently thioguanine is solely used as treatment for inflammatory bowel disease after azathioprine and/or mercaptopurine failure. This study aimed to determine the safety, effectiveness, and 12-month drug survival of thioguanine in thiopurine-naïve patients with inflammatory bowel disease. METHODS: A retrospective cohort …

nl (code pays fourni par la source)

4 citations Inflammatory Bowel Diseases
Accès ouvert 2022 article OpenAlex

Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test–Based Screening

Pieter H.A. Wisse, Nicole Stephanie Erler, Sybrand Y. de Boer, Bert den Hartog et autres

BACKGROUND: The adenoma detection rate (ADR) is an essential quality indicator for endoscopists performing colonoscopies for colorectal cancer (CRC) screening as it is associated with postcolonoscopy CRCs (PCCRCs). Currently, data on ADRs of endoscopists performing colonoscopies in fecal immunochemical testing (FIT)-based screening, …

nl (code pays fourni par la source)

67 citations Annals of Internal Medicine
Accès ouvert 2022 conference-abstract OpenAlex

P592 Effectiveness and safety of thioguanine in thiopurine-naïve Inflammatory Bowel Disease patients

Femke Crouwel, Ahmed B. Bayoumy, Chris J J Mulder, Job Peters et autres

Abstract Background Currently thioguanine is considered as off-label rescue therapy for Inflammatory Bowel Disease (IBD) after conventional thiopurine failure. This study aimed to determine the safety, effectiveness and 12-month drug tolerability of thioguanine in thiopurine-naïve IBD patients. Methods We performed an analysis …

nl (code pays fourni par la source)

0 citations Journal of Crohn s and Colitis
Accès ouvert 2018 article OpenAlex

Risk Factors and Clinical Outcomes of Head and Neck Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Loes H.C. Nissen, Lauranne A. A. P. Derikx, A Jacobs, Carla ML van Herpen et autres

Background: Immunosuppressed inflammatory bowel disease (IBD) patients are at increased risk to develop extra-intestinal malignancies. Immunosuppressed transplant patients show increased incidence of head and neck cancer with impaired survival. This study aims to identify risk factors for oral cavity (OCC) and pharyngeal …

nl (code pays fourni par la source)

14 citations Inflammatory Bowel Diseases
2009 article OpenAlex

Hyperglycemia Reduces Gastric Secretory and Plasma Pancreatic Polypeptide Responses to Modified Sham Feeding in Humans

W. F. Lam, Ad Masclee, Sybrand Y. de Boer, Cornelis B.H.W. Lamers

We have investigated the effect of acute stable hyperglycemia on gastric acid secretion and serum gastrin and pancreatic polypeptide (PP) release. Gastric acid output was measured under basal conditions and in response to modified sham feeding (MSF) in 7 healthy volunteers on …

nl (code pays fourni par la source)

46 citations Digestion
Accès ouvert 2007 article OpenAlex

NQO1 and NFE2L2 polymorphisms, fruit and vegetable intake and smoking and the risk of colorectal adenomas in an endoscopy‐based population

Mariken J. Tijhuis, Marleen H. P. W. Visker, Jac M. M. J. G. Aarts, Wijnand Laan et autres

Both environment and genetics contribute to the pathogenesis and prevention of colorectal neoplasia. NAD(P)H: quinone oxidoreductase (NQO1) is a detoxification enzyme that is polymorphic and inducible. We investigated interactions between lifestyle factors and polymorphisms in NQO1 and its key regulatory transcription factor …

nl (code pays fourni par la source)

17 citations International Journal of Cancer
2007 article OpenAlex

Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.

Dirk J. de Jong, D. J. Bac, Gie Tan, Sybrand Y. de Boer et autres

BACKGROUND: In previous trials, budesonide 6 mg/day was able to prolong the time to relapse in patients with quiescent Crohn's disease and budesonide 9 mg/day was effective in active disease with limited side effects. The aim of this study was to compare …

nl (code pays fourni par la source)

27 citations PubMed

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.